Evidence construction of Silibinin capsules against alcoholic liver disease based on a meta-analysis and systematic review.
- 2025-02-04
- Systematic Review · n = 221
- Frontiers in pharmacology 16
- Yan Wang
- Wenmin Yang
- Yuan Yang
- Xingning Liu
- Lanfen Peng
- Qi Huang
- Kongli Fan
- Rui Hu
- Jinyu Yi
- Xin Zhong
- Jing Li
- Jialing Sun
- Xiaozhou Zhou
- PubMed: 39968181
- DOI: 10.3389/fphar.2025.1516204
- High evidence
- Clinical
Effective Rate [OR = 3.60, 95% CI (2.28, 5.70)]
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes